Status:
COMPLETED
Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration (FNA) With Rapid On-site Evaluation (ROSE) of Cytopathology vs. EUS-guided Fine Needle Biopsy (FNB) Alone in the Diagnosis of Pancreatic Solid Lesions
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Solid Pancreatic Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Currently, the best way to evaluate pancreatic masses is through endoscopic-guided needle sampling of the mass to determine the diagnosis by looking at the acquired tissue under a microscope. This is ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patients referred for EUS evaluation of a definite solid pancreatic mass noted on computed tomography(CT)/Magnetic resonance imaging(MRI)/EUS, in which malignancy is suspected with no previous histological diagnosis
Exclusion
- Age \< 18 years, pregnant patients.
- Uncorrectable coagulopathy Prothrombin time (PT) \>50% of control, Partial Thromboplastin time (PTT) \>50 sec, or International normalized ratio (INR) \>1.5 and/or uncorrectable thrombocytopenia platelet count\<50, 000109/L.
Key Trial Info
Start Date :
February 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2019
Estimated Enrollment :
235 Patients enrolled
Trial Details
Trial ID
NCT03435588
Start Date
February 14 2018
End Date
December 15 2019
Last Update
December 11 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada
2
Vancouver General Hospital
Vancouver, British Columbia, Canada
3
Moncton Hospital
Moncton, New Brunswick, Canada
4
The Ottawa Hospital
Ottawa, Ontario, Canada